Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Dammann

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
Deutsche Medizinische Wochenschrift (1946)|May 3, 1985
[Inhibition of acid secretion in smokers caused by the new imidazole-H2-receptor antagonist etintidine]H G Dammann, M Rehner, W R Gottlieb, et al.
Progress in Clinical and Biological Research|January 1, 1987
Nocloprost, a novel prostanglandin E2 analog: significant reduction of aspirin induced grastrointestinal lesions in manH G Dammann, M Dreyer, T A Walter, et al.
Arzneimittel-Forschung|January 1, 1984
[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human]C Staiger, B Koroknay, J X DeVries, et al.
British Journal of Clinical Pharmacology|July 1, 1984
Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteersC Staiger, B Korodnay, J X Devries, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987
Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trialR Naccaratto, M Cremer, H G Dammann, et al.
Deutsche Medizinische Wochenschrift (1946)|April 20, 1984
[Prostaglandins in the treatment of duodenal ulcer disease]P Müller, B Simon, H G Dammann, et al.
Hepato-Gastroenterology|October 1, 1986
Nocturnal acid suppression with a new H2 receptor antagonist--nizatidineH G Dammann, W R Gottlieb, T A Walter, et al.
Digestion|January 1, 1986
20 versus 30 mg omeprazole once daily: effect on healing rates in 115 duodenal ulcer patientsW Hüttemann, H G Rohner, G duBosque, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2004
Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjectsH-G Dammann, M Saleki, M Torz, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1991
Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazoleW Londong, H Barth, H G Dammann, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
Deutsche Medizinische Wochenschrift (1946)|May 3, 1985
[Inhibition of acid secretion in smokers caused by the new imidazole-H2-receptor antagonist etintidine]H G Dammann, M Rehner, W R Gottlieb, et al.
Progress in Clinical and Biological Research|January 1, 1987
Nocloprost, a novel prostanglandin E2 analog: significant reduction of aspirin induced grastrointestinal lesions in manH G Dammann, M Dreyer, T A Walter, et al.
Arzneimittel-Forschung|January 1, 1984
[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human]C Staiger, B Koroknay, J X DeVries, et al.
British Journal of Clinical Pharmacology|July 1, 1984
Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteersC Staiger, B Korodnay, J X Devries, et al.
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987
Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trialR Naccaratto, M Cremer, H G Dammann, et al.
Deutsche Medizinische Wochenschrift (1946)|April 20, 1984
[Prostaglandins in the treatment of duodenal ulcer disease]P Müller, B Simon, H G Dammann, et al.
Hepato-Gastroenterology|October 1, 1986
Nocturnal acid suppression with a new H2 receptor antagonist--nizatidineH G Dammann, W R Gottlieb, T A Walter, et al.
Digestion|January 1, 1986
20 versus 30 mg omeprazole once daily: effect on healing rates in 115 duodenal ulcer patientsW Hüttemann, H G Rohner, G duBosque, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2004
Effects of buffered and plain acetylsalicylic acid formulations with and without ascorbic acid on gastric mucosa in healthy subjectsH-G Dammann, M Saleki, M Torz, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1991
Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazoleW Londong, H Barth, H G Dammann, et al.
Pageof 21